Global

Oncology Experts

Stephen M. Sykes


Department of Cancer Research
Fox Chase Cancer Center
United States of America

Biography

Stephen M. Sykes,Educational Background: PhD, Cell and Molecular Biology, University of Pennsylvania, Philadelphia, PA, 2007 BS, Biochemistry, Mount Allison University, Sackville, NB, 2000 AAS, Biology, Ulster County Community College, Stone Ridge, NY, 1997. Honors & Awards : Junior Scholar, American Society of Hemotology, 2014-2016 Tosteson Postdoctoral Fellowship Award, 2011 Eugene Goldwasser Fellowship in Hematology, International Society of Hematology, 2011

Research Interest

Normal and Malignant Hematopoietic Stem and Progenitor Cells Defining the molecular circuitry that distinguishes leukemia stem and progenitor cells from their healthy counterparts. Identifying and targeting critical regulators of redox biology to overcome chemotherapy resistance in acute myeloid leukemia (AML). Targeting ER stress responses to treat certain genetic sub-types of AML.

Publications

  • Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., & McMahon, S. B. (2006). Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Molecular cell, 24(6), 841-851.

  • Lee, D., Sykes, S. M., Kalaitzidis, D., Lane, A. A., Kfoury, Y., Raaijmakers, M. H., ... & Scadden, D. T. (2014). Transmembrane inhibitor of RICTOR/mTORC2 in hematopoietic progenitors. Stem cell reports, 3(5), 832-840.

  • Kalaitzidis, D., Sykes, S. M., Wang, Z., Punt, N., Tang, Y., Ragu, C., ... & Anastasiou, D. (2012). mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. Cell stem cell, 11(3), 429-439.

  • Placke, T., Faber, K., Nonami, A., Putwain, S. L., Salih, H. R., Heidel, F. H., ... & Armstrong, S. A. (2014). Requirement for CDK6 in MLL-rearranged acute myeloid leukemia. Blood, 124(1), 13-23.

  • Sykes, S. M., Lane, S. W., Bullinger, L., Kalaitzidis, D., Yusuf, R., Saez, B., ... & Acharya, S. S. (2011). AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell, 146(5), 697-708.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America